E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications.

E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications.
复制标题

E3泛素连接酶在乳腺癌转移中的作用:病理功能和临床意义的系统综述。

DOI:
10.3389/fonc.2021.752604
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Lan J
Lan J
中科院分区:
医学3区
文献类型:
--
作者:
Wang Y;Dai J;Zeng Y;Guo J;Lan J

文献摘要

参考文献

被引文献

相似文献

女性乳腺癌已成为全球最常见的癌症。虽然在早期诊断和适当治疗下预后良好,但乳腺癌转移严重导致死亡。转移过程包括细胞上皮-间质转化、侵袭、迁移和定殖,是由基因突变和改变的蛋白质表达指导的分子事件的多步骤级联。蛋白质的泛素修饰在大多数生物过程中起着共同的作用。E3泛素连接酶是蛋白质泛素化的关键调控因子,决定着泛素化蛋白的命运。E3泛素连接酶靶向广谱底物。许多E3泛素连接酶的异常功能可以影响癌细胞的生物学行为,包括乳腺癌转移。在这篇综述中,我们提供了这些连接酶的概述,总结了E3参与的转移过程,并全面描述了E3泛素连接酶的作用。此外,我们根据其结构对E3泛素连接酶进行了分类,并分析了它们与乳腺癌患者生存的关系。最后,我们考虑如何将我们的知识用于E3在转移性乳腺癌的治疗干预或预后评估中的效力。
Female breast cancer has become the most commonly occurring cancer worldwide. Although it has a good prognosis under early diagnosis and appropriate treatment, breast cancer metastasis drastically causes mortality. The process of metastasis, which includes cell epithelial–mesenchymal transition, invasion, migration, and colonization, is a multistep cascade of molecular events directed by gene mutations and altered protein expressions. Ubiquitin modification of proteins plays a common role in most of the biological processes. E3 ubiquitin ligase, the key regulator of protein ubiquitination, determines the fate of ubiquitinated proteins. E3 ubiquitin ligases target a broad spectrum of substrates. The aberrant functions of many E3 ubiquitin ligases can affect the biological behavior of cancer cells, including breast cancer metastasis. In this review, we provide an overview of these ligases, summarize the metastatic processes in which E3s are involved, and comprehensively describe the roles of E3 ubiquitin ligases. Furthermore, we classified E3 ubiquitin ligases based on their structure and analyzed them with the survival of breast cancer patients. Finally, we consider how our knowledge can be used for E3s’ potency in the therapeutic intervention or prognostic assessment of metastatic breast cancer.
DOI: 10.1080/15384101.2015.1104441
发表时间: 2015
期刊: Cell cycle (Georgetown, Tex.)
影响因子: --
作者:
Adam MG;Matt S;Christian S;Hess-Stumpp H;Haegebarth A;Hofmann TG;Algire C
通讯作者: Algire C
DOI: 10.1186/s12885-018-4188-x
发表时间: 2018-03-13
期刊: BMC cancer
影响因子: 3.8
作者:
David D;Surendran A;Thulaseedharan JV;Nair AS
通讯作者: Nair AS
DOI: 10.1074/jbc.m111.321083
发表时间: 2012-05-04
影响因子: 4.8
作者:
Ahmed, Syed Feroj;Deb, Satamita;Ghosh, Mrinal K.
通讯作者: Ghosh, Mrinal K.
DOI: 10.1038/onc.2015.214
发表时间: 2016-03-24
期刊: ONCOGENE
影响因子: 8
作者:
Chang, Y-W;Tseng, C-F;Su, J-L
通讯作者: Su, J-L
DOI: 10.18632/oncotarget.12986
发表时间: 2016-11-29
期刊: Oncotarget
影响因子: --
作者:
Ahn JS;Ann EJ;Kim MY;Yoon JH;Lee HJ;Jo EH;Lee K;Lee JS;Park HS
通讯作者: Park HS